Skip to main content
. 2010 May 20;10:217. doi: 10.1186/1471-2407-10-217

Figure 3.

Figure 3

14-3-3-σ values measured in serum of patients with breast cancer metastatic disease before the first C(0) and successive C(1...5) chemotherapy cycles, in patients with "continuous decline" biomarker pattern.